Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use
Two researchers in a laboratory each holding a 3 mL peptide vial, shelves of vials behind them
Compounds · Sourced Dosing Ranges

Research with confidence.

Pick your peptide, enter your vial size and how much water you're adding, and we'll tell you exactly what to draw — with a week-by-week plan and the research behind every number.

52Compounds
120+Cited Studies
10Categories
0Sponsored Claims
Mixing Calculator
Concentration
Doses per vial
See the full plan & research →

Mixing maths only · for research use · not a dosing recommendation

What this site does differently

Most peptide calculators stop at "mL per dose." Ours keeps going — the doses used in real research, a week-by-week plan, and how many vials you will get through.

01

Knows your peptide

Pick a peptide and the calculator pulls up its dose range, how to take it and how long it lasts — then works out what each of those doses means for your mix, down to the line on the syringe.

Try it →
02

Shows the whole range

Research reports a range, not one magic number. You see the low, middle and high end separately — and how solid the evidence behind each one actually is.

See the chart →
03

Every number is sourced

Behind every number is the study it came from — the authors, the journal, the year, and a plain-English line on what that paper actually showed. All of it one click away.

Open the library →

Browse by type

peptides, sorted into groups.

Methodology

Where the numbers come from

Dose ranges on this site are pulled from three tiers of evidence, and we label which tier a compound sits in rather than flattening them together:

  • Clinical trial data — registered human trials with published dose-escalation arms (the GLP-1 class, tesamorelin, elamipretide, bremelanotide).
  • Preclinical research data — where only weight-based research dosing exists, we say so and give the reported mg/kg rather than implying a human equivalent.
  • Observational and grey literature — commonly reported research-community ranges, flagged explicitly as low-confidence.

See every citation in the Research Library →

Evidence tiers at a glance

TierCompoundsMeaning
ClinicalHuman trial dosing published
PreclinicalPreclinical research only
LimitedSparse or community-reported

New to this? Start here

Three short guides covering the basics, in plain English.

Guide

How to mix a vial

Which water to use, how to add it without wrecking the peptide, and the simple maths for working out your concentration.

Read →
Guide

How to read a syringe

What a "unit" actually means, how the different syringe sizes compare, and the mg / mcg / IU mix-up that catches nearly everyone out.

Read →
Guide

How to store it

How long a vial lasts before and after mixing, what temperature it needs, and the mistakes that ruin a vial.

Read →
A calculator and an orange-capped insulin syringe on a laboratory bench
Calculator

Peptide Mixing Calculator

Pick your peptide, tell us what's in the vial and how much water you're adding, and we'll show you exactly what to draw — plus a week-by-week plan and the doses used in research.

1Set Up Your Mix

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer

Draw To This Line
That's This Many mL
Doses In The Vial

2Week-By-Week Plan —

WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used

3Common Doses —

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About This Peptide

Where These Numbers Come From

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.
A rack of clear 3 mL glass vials in rows on a laboratory bench
Reference

Master Dosage Chart

Every compound in the database with its class, common vial strengths, reported research range, cadence, route, half-life, and evidence tier. Sort or filter, then jump straight into the calculator.

PeptideTypeDose RangeHow OftenHow To Take ItHalf-lifeEvidence

Ranges reflect figures reported in the cited literature. They are not recommendations, and the presence of a compound in this table is not an endorsement of its use.

Research Library

Peptide Research Literature — Table of Contents

Every study behind the numbers on this site, sorted by type of peptide. Each entry gives the authors, the journal and the year, plus a plain-English line on what that paper actually showed — so you can weigh the evidence yourself instead of taking a number on trust.

On citation practice. Entries name the primary study and its venue rather than reproducing abstracts. Search links resolve to PubMed so you can pull the record and full text yourself. Where a compound has no peer-reviewed human literature, the section says so plainly instead of padding the list.
Fundamentals

Handling & Measurement Guides

The mechanical background the calculator assumes you already know.

Bacteriostatic water running down the inner wall of a 3 mL glass vial

How To Mix A Vial

Lyophilised peptide arrives as a dry cake or powder under vacuum. Reconstitution is the act of dissolving that cake into a known volume of sterile diluent so that a measurable fraction of it can be withdrawn.

Which water to use

Bacteriostatic water is sterile water containing roughly 0.9% benzyl alcohol, which suppresses microbial growth and makes multi-draw vials viable for a matter of weeks under refrigeration. Sterile water for injection contains no preservative and is generally reserved for single-draw work. A handful of compounds — copper peptides and some acetate salts among them — have documented compatibility quirks with benzyl alcohol, so check the compound profile before defaulting.

Step by step

  1. Let the vial reach room temperature before opening. Cold glass plus cold powder makes for slow, incomplete dissolution.
  2. Swab both stoppers with isopropyl alcohol and let them dry.
  3. Draw the diluent, then angle the needle so the stream runs down the inner wall of the vial rather than jetting directly onto the cake. Peptide bonds are mechanically fragile.
  4. Let the vacuum pull the diluent in; don't force the plunger.
  5. Swirl gently or let it sit. Never shake. Agitation shears peptide chains and denatures them.
  6. Wait until the solution is completely clear. Persistent cloudiness or visible particulate after several minutes means something is wrong — don't proceed.

The maths

concentration (mg/mL) = vial strength (mg) ÷ diluent volume (mL)
volume per dose (mL) = dose (mg) ÷ concentration (mg/mL)
syringe units (U-100) = volume (mL) × 100

The diluent volume is a free choice, and it is the only lever you have over measurement precision. A 5 mg vial in 1 mL gives 5 mg/mL, which puts a 250 mcg dose at 5 units — legible, but every half-unit of error is a 10% dosing error. The same vial in 2.5 mL gives 2 mg/mL and puts that dose at 12.5 units, where the same absolute error matters far less. Dilute enough that your target lands somewhere in the mid-range of the barrel.

Reading Your Syringe

Everything on this site assumes a standard 1 mL U-100 insulin syringe — the ordinary kind, marked 0 to 100. The U-100 label means it is calibrated for insulin at 100 units per millilitre, and that is what fixes 1 unit at 0.01 mL.

This is where most people go wrong. A unit is a volume, not an amount of peptide. Ten units drawn from a weak mix and ten units from a strong one fill the syringe to exactly the same line — but one holds five times more peptide than the other. That is why the calculator always asks what you put in the vial.

What it saysWhat it means
U-100The calibration. 100 units of insulin per millilitre — which is what fixes 1 unit at 0.01 mL.
1 mLThe barrel holds 1 millilitre in total, marked out as 100 units.
1 unit0.01 mL. A hundredth of the barrel. This is a volume, not an amount of peptide.
1–2 unitsThe smallest gap between marks, so the smallest amount you can measure with confidence.

The unit chain

Four units of measure show up constantly and they are not interchangeable:

  • mg — milligram. Mass. What vials are labelled in.
  • mcg (µg) — microgram. 1 mg = 1000 mcg. What most non-GLP-1 research doses are expressed in.
  • IU — international unit. A biological activity measure, not a mass. Conversion to mg is compound-specific: growth hormone is conventionally ~3 IU per mg, hCG is a different scale entirely. Never assume a universal factor.
  • Syringe units — the marks on the barrel. 1 unit = 0.01 mL. Tells you nothing on its own until you know how strong your mix is.

Storage & Stability

Lyophilised peptide is comparatively robust: kept dry, dark, and at −20 °C, most compounds in this database are stable for a year or more, and many tolerate 2–8 °C for months. The moment water is introduced, that changes.

StateTemperatureTypical windowNotes
Lyophilised, sealed−20 °C12–24 monthsProtect from light and moisture
Lyophilised, sealed2–8 °C1–3 monthsAcceptable short-term
Reconstituted, bacteriostatic2–8 °C2–4 weeksCompound-dependent; some far shorter
Reconstituted, sterile water2–8 °C~24 hoursNo preservative — single session
Any stateRoom tempHoursDegradation accelerates sharply

Practical points

  • Do not freeze a reconstituted vial. Ice crystal formation and repeated freeze–thaw cycles are among the most destructive things you can do to a peptide in solution.
  • Copper peptides (GHK-Cu) and several others are photosensitive. Amber vials or foil, not a clear vial on a shelf.
  • Store vials upright, away from the fridge door where temperature swings are largest.
  • Date the vial at reconstitution. Memory is not a stability record.
  • Cloudiness, colour change, or visible particulate that develops after a clear reconstitution means the solution has failed. Discard it.
Scope note. These guides describe laboratory handling of research chemicals. They are not instructions for preparing anything for administration to a person or animal, and nothing on this site should be read as endorsing that use.
About This Site

Editorial Policy

How the numbers on this site were put together, how we grade the evidence behind them, and what we will not do with them.

Read this first. This site is a reference for laboratory and educational use. It is not medical advice, not a prescription, and not instructions for administering anything to a person or animal. If you are making a decision that affects someone's health, talk to a qualified clinician.

Where the numbers came from

We think you should know exactly how this was built, because it changes how much weight the figures deserve.

The dose ranges and the citations were assembled by an AI system from its training knowledge of the published peptide literature. They were not compiled by researching each compound one at a time, and the individual citations have not been checked against the source records. Author names, journals and years may contain errors.

That is also why every reference on this site links to a PubMed search rather than a specific article ID. A search will take you to the real record if the paper exists. A fabricated ID would look authoritative and lead nowhere, which is worse than no link at all.

Three parts of the site do not come from that process:

  • Product compositions — vial strengths, blend ratios and what we stock come from us directly.
  • Blend arithmetic — the per-component splits are calculated from those compositions, so they are exact.
  • The "Newest Studies" panel — queried live from Europe PMC each time you open a compound. Those are real, current records, and nobody has reviewed them.

What this means in practice: treat the ranges as a well-informed starting point for your own reading, not as a verified bibliography. Follow the links. If a number matters to a decision you are making, check it at the source.

How we grade evidence

Every compound carries an evidence tier, and we would rather show you a weak one honestly than dress it up:

TierWhat it means
ClinicalHuman trial or approved-label dosing has been published for this compound.
PreclinicalLaboratory and animal data only. No human dosing trials.
LimitedSparse evidence, often from a single research programme, or figures reported only within the research community.

Week-by-week schedules carry their own label so you can see where each one originated — a published label, a clinical trial protocol, a commonly used protocol, one we built from a compound's own cited range, or an OptimalDosages protocol anchored to a target we chose. Where no source publishes a schedule, the page says so rather than implying one exists.

What we don't do

  • We don't change dose figures automatically. New papers appear in the live feed, but ranges, schedules and evidence tiers only change after a person reviews the evidence.
  • We don't convert weight-based figures into draw volumes. Where a dose was reported as mg/kg, the calculator refuses to turn it into a syringe reading and says why.
  • We don't rewrite citation titles. If a paper studied a different molecule or a different route, its description says so, even where that sits awkwardly next to the product.
  • We don't present community convention as trial data. Protocols with no published basis are labelled as such.

Updates and corrections

A literature check runs weekly against Europe PMC, rotating through the catalogue so every compound is reviewed roughly monthly. It flags new human trials, dose findings, safety signals and retractions of papers we cite. It reports only — it cannot edit the site.

If you find an error, tell us and we will fix it. Corrections to dose figures or evidence tiers are made in place, and the build identifier in the footer changes whenever the site does, so you can tell whether you are looking at a current version.

Commercial interests

This section needs completing before launch. It should state who operates this site, whether the same people sell the compounds described here, and whether anyone pays for placement or favourable treatment. A reader who works out a commercial relationship that was not disclosed will discount everything else on the page — disclosure costs far less than discovery.
Questions or corrections: optimaldosages@gmail.com